Protagonist Therapeutics (PTGX) EBT Margin (QoQ) (2017 - 2026)
Protagonist Therapeutics (PTGX) EBT Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Protagonist Therapeutics | 8.88 Bn | 8.88 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,189.00 |
| Dec 31, 2025 | 24,702.00 |
| Sep 30, 2025 | -21,101.00 |
| Jun 30, 2025 | -58,270.00 |
| Mar 31, 2025 | -12,214.00 |
| Dec 31, 2024 | 80,035.00 |
| Sep 30, 2024 | 3,159.00 |
| Jun 30, 2024 | -83,358.00 |
| Mar 31, 2024 | 2,796.00 |
| Jun 30, 2022 | -470,587.00 |
| Mar 31, 2022 | 16,805.00 |
| Dec 31, 2021 | -9,966.00 |
| Sep 30, 2021 | 103,304.00 |
| Jun 30, 2021 | -97,393.00 |
| Mar 31, 2021 | -5,349.00 |
| Dec 31, 2020 | -27,507.00 |
| Sep 30, 2020 | 23,503.00 |
| Jun 30, 2020 | 25,154.00 |
| Mar 31, 2020 | -103,482.00 |
| Dec 31, 2019 | 88,778.00 |